drugset / Trial / NCT02651792

Ketamine- Propofol Versus Pethidine- Propofol in ERCP

NCT02651792

Phase 2 Completed 50 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators aim to investigate the differences between ketamine propofol and pethidine propofol during ERCP in respect to endoscopist satisfaction.

Timeline

Start
2015-01
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 1 mg/kg Intravenous
Comparator Meperidine Unknown 1.1 mg/kg
Comparator Propofol Small molecule 1.2 mg/kg

Indications

No indication recorded.